Pharmaceuticals News
|
Pharmaceutical companies are showing an increased interest in big data, focused on areas like drug discovery and with a realization this can give them a competitive advantage. This might not come so easily, however, without a joined-up strategy.
|
|
Pharmaceutical organizations are increasingly reliant upon automated systems and computers, from manufacturing to laboratory release testing. This has brought a renewed regulatory focus on the subject of data integrity.
|
|
Washington -
The company Quascenta has simplified cleaning validation for active pharmaceutical ingredient manufacturers through a new software package called eResidue. Cleaning validation is a key process, and it avoids cross-contamination.
|
|
University of California San Diego School of Medicine have completed an early phase clinical trial to evaluate the effectiveness of an established drug for the treatment of autism.
|
|
Bethesda -
A brand of herbal coffee has been recalled from the market after it was discovered that the product contained an unintended active pharmaceutical ingredient, designed to control erectile dysfunction.
|
|
Dublin -
Microbiologists from a range of pharmaceutical and healthcare companies convened in Dublin to attend a conference discussing how to effectively monitor the built environment for risks in relation to drug product manufacturing.
|
|
Birmingham -
The manufacture of medicines is at risk from cross-contamination from people, a result of the shedding of microorganisms. In February a special two-day conference considered how best to manage this risk.
|
|
Concerns over the proliferation of synthetic chemicals and pesticides, in particular, gave rise to the environmental movement in the 1960s. But scientific analysis of synthetic chemical pollution and their ecological impacts is disproportionately low.
|
|
Vermont -
The belief that most drugs in sewage are stashes of illegal narcotics flushed down toilets by criminals appears to be a myth. Most drugs in sewage systems are excreted by people who have been prescribed them.
|
|
In the latest pharmaceutical news round-up there is a new push to eliminate polio, a new treatment for COPD, and unfortunate news that a patient has died after taking an anti-psychotic medication.
|
|
India wants to get in on the oil-for-loans deal that Venezuela has with China, in the hopes of recouping some of the millions of dollars in payments owed to India's largest pharmaceutical companies.
|
|
As we do on a regular basis, Digital Journal has reviewed the latest developments within the pharmaceutical sector. Here AstraZeneca completes takeover of Takeda's respiratory business and Ferring Pharmaceuticals have a new nocturia treatment.
|
|
Washington -
The U.S. public-sector science base, the National Institutes of Health (NIH), has announced it will suspend all research related to sterile medicinal products after the test areas were found to be out of compliance with good practices.
|
|
Pharmaceutical company Novartis experienced mixed results during the first quarter of 2016. Sales showed a decline, however the company is preparing to launch a significant new anti-seizure medication.
|
|
Two very different drugs are making progress in news announced this week. The FDA has approved a new leukemia medication, and work is progressing on a Zika virus treatment.
|
|
This week has seen progress updates issued for new drug products for rheumatoid arthritis, skin dermatitis, and for hepatitis. Each of the products is at the clinical trial stage, and three of the drugs on offer are the result of partnerships.
|
|
The head of GlaxoSmithKline is to retire, amid some concerns about the company’s performance. Digital Journal presents this and other news from the pharmaceutical sector, including mergers and FDA warnings.
|
|
The last couple of years have seen a slight lowering in the number of cases brought against medical companies; however, at the same time, there was an increase in the level of fines paid out.
|
|
As we do at regular intervals, Digital Journal dips into the latest news stories relating to the colorful world of pharmaceuticals. This week there are new drugs announced and old scores to settle.
|
|
By AFP
Brussels -
Belgian federal prosecutors are seeking to bring to court seven pharmaceutical executives accused of supplying a Mexican drug baron with the key ingredients for crystal meth, they said Wednesday.
|
|
Mumbai -
The U.S. Food and Drug Administration has issued a warning notice to Ipca Laboratories, which is based in India, for data integrity issues.
|
|
Human society needs a new generation of antimicrobials to overcome the problem of multi-drug resistance. A key question stemming from this is who should pick up the bill?
|
|
U.S. healthcare colossus Johnson and Johnson saw a drop in its share value by 6 percent during 2015, according to the company’s latest financial statement.
|
|
Washington -
A consent decree has been opened against Downing Labs LLC, of Dallas, Texas, together with the holding company. The action has been initiated by U.S. District Judge Sam A. Lindsay.
|
|
We are only into the early days of 2016 but this hasn’t slowed the actions of companies doing anything to protect their share prices. Two big pharmaceutical companies have already announced plant closures and layoffs.
|
|
Concerns have been expressed over the past few years about the independence of clinical trials, due to the funding of some trials by corporations with vested interests. New data suggests this is now the norm rather than the exception.
|
|
The former, and controversial, CEO of Turing Pharmaceuticals and KaloBios Pharmaceuticals Inc., Martin Shkreli, has been detained for securities fraud.
|
|
In news that will no doubt please the shareholders of pharmaceutical companies, the global spend on drug products is set to rise by 30 percent by the year 2020. This means an annual pay-out of $1.4 trillion.
|
|
London -
The Good Pharma Scorecard is a system that ranks drugs based on their transparency and ethical practices. A review of some big pharma companies reveals several inconsistencies.
|
|
The U.S. Food and Drug Administration (FDA) has placed an import ban on the drug maker Megafine Pharma's Nashik site in Maharashtra, India.
|
apis-340359 apis-340356 apis-340152 apis-336370 apis-336296 apis-335846 apis-327862 apis-326614 apis-315552 apis-306286 apis-306274 apis-305420 apis-305088 apis-304125 apis-303304 apis-302220 apis-301050 apis-300923 apis-300304 apis-300074 apis-298082 apis-296677 apis-296192 apis-294885 apis-294516 apis-293054 apis-293053 apis-289774 apis-289473 apis-288112
Pharmaceuticals Image
Eli Lilly's global headquarters, Indianapolis, Indiana Guanaco152003
Dr. Olumayokun Olajide's research will now look to produce compound derivatives of punicalagin for a drug that would treat neuro-inflammation, slowing down the progression of Alzheimer's University of Huddersfield
Biogen is an American global biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurodegenerative, hematologic, and autoimmune diseases to patients worldwide. Biogen
A variety of statin drugs
U.S. drug company sues Canada for trying to lower cost of $700K-a-year drug Alexion Pharmaceuticals
Project Team at work: Expertise helps AbbVie develop and enhance products and therapies to treat conditions including HIV, arthritis, immunological and metabolic disorders, heart disease, and cancer. © AbbVie Inc.
Sativex contains marijuana-derived ingredients. Associated Press
Medicine vials on display at making Pharmaceuticals 2015.
|
|
